Remote Patient Monitoring Companies: Types, Models, and How They Compare in 2026

Search "remote patient monitoring companies" today and you will find a crowded, confusing field. The category has expanded fast, pushed by an aging population, the shift to value-based care, and Medicare's steady expansion of reimbursable remote care. The problem for a provider organization is that the companies returned by that search are not the same kind of business. Some sell software. Some ship devices. Some supply a full clinical team. Comparing them head to head is like comparing a car, an engine, and a chauffeur because all three showed up under "transportation."

This guide fixes that. Instead of a ranked list, it gives you a map of the market: the distinct types of remote patient monitoring companies, what each actually delivers, which one fits which kind of buyer, and the signals that separate a strong partner from a weak one. Once you can see the categories clearly, choosing becomes far easier. And when you are ready to evaluate specific vendors, we link to our detailed decision guide at the end.

The remote patient monitoring market in 2026

Remote patient monitoring has moved from a telehealth novelty to core clinical infrastructure. Providers face rising chronic disease prevalence, tighter margins, and payment models that increasingly reward outcomes over volume. Remote monitoring answers all three at once by extending a practice's clinical reach into the patient's home between visits.

Three trends define the current landscape. First, consolidation: the field is maturing, and buyers increasingly prefer one accountable vendor over a patchwork of point tools. Second, cellular-connected devices have become the standard, because they transmit automatically without Wi-Fi, Bluetooth pairing, or an app, which removes the biggest barrier to patient adherence. Third, program stacking: the leading companies no longer offer monitoring alone but layer complementary Medicare programs so a single patient can be served across several reimbursable services. Understanding those trends is useful, but the decision still comes down to what type of company you are actually evaluating.

The five types of remote patient monitoring companies

Nearly every company that appears under this search falls into one of five categories. The categories differ most in one respect: how much of the operational and clinical work they take on, versus how much they leave to you.

1. Software-only platforms

These companies provide a dashboard: a place to view patient data, document time, and generate billing reports. They are often well designed and affordable. The catch is that software does not monitor patients. Your staff still reviews the data every day, makes the monthly patient contact, and manages escalation. A software-only platform is a tool, not a team, so it solves the visibility problem while leaving the staffing problem exactly where it was.

2. Device and connectivity vendors

These companies specialize in the hardware and the data pipe: FDA-cleared blood pressure cuffs, glucometers, scales, and pulse oximeters, plus the cellular connectivity that gets readings from the home to a dashboard. They are essential to any program and some are excellent at logistics and fulfillment. But like software-only vendors, they hand you the inputs and leave the clinical work and billing to your team.

3. Fully managed clinical partners

These companies supply the whole operation: the devices, the software, and, critically, the clinical team that enrolls patients, reviews data daily, makes the monthly contact, documents time, and prepares the billing file. The practice keeps clinical ownership and direction while the partner runs the day-to-day program. This is the only model that actually removes the staffing barrier, which is why it has become the fastest-growing segment of the market. It is also the model that best supports practices without spare capacity to build a program in-house.

4. Enterprise and hospital-at-home providers

These companies are built for large health systems running high-acuity use cases: post-discharge monitoring to prevent readmissions, and acute hospital-at-home programs that substitute for inpatient stays. They tend to carry deep enterprise EHR integrations and operate within distinct regulatory frameworks. They are powerful for systems with the scale and internal resources to match, and often more than a typical practice or group needs.

5. Condition-specific point solutions

These companies focus on a single disease state or device type, such as continuous glucose monitoring for diabetes or cardiac device monitoring. They can be excellent within their niche. The tradeoff is fragmentation: a practice managing patients with multiple conditions can end up stitching together several point solutions, each with its own dashboard, contract, and billing workflow.

The decision that matters most: who does the clinical work

Cut through every feature list and one question decides more than any other. When a patient's blood pressure spikes on a Tuesday, who reviews it, who calls the patient, and who documents the interaction? If the answer is your staff, you have bought a tool. If the answer is the company's clinical team, you have bought a service.

This is the full-service versus software-only fork, and it determines whether a remote monitoring program actually reduces your team's workload or quietly adds to it. Many programs stall not because the technology failed but because no one at the practice had time to work the data every day. A fully managed partner is designed to prevent exactly that failure. For a complete framework on evaluating a specific vendor once you have chosen a model, see our guide on how to choose a remote patient monitoring company.

How company type maps to buyer type

There is no single best type of remote patient monitoring company. There is only the best fit for a given organization's size, resources, and goals. The mapping below is a starting point.

Nsight Health builds fully managed programs across these buyer types, including dedicated approaches for ACOs and health systems.

What separates the best remote patient monitoring companies

Within any category, quality varies. These are the signals that consistently separate a strong company from a weak one. Use them as a quick screen, then apply a full evaluation framework to your finalists.

For the full nine-point evaluation, including contracting terms and data security, work through our vendor decision guide.

The fully managed clinical partner category, and where Nsight Health fits

Among the five types, the fully managed clinical partner is the model built to deliver proactive care without adding staff, and it is the category where Nsight Health operates. Nsight is not a software platform you have to run and not a device vendor that ships hardware and steps back. Nsight supplies the devices, the software, and a U.S.-based clinical team employed by Nsight Health that monitors patients 24/7, handles enrollment and engagement, documents time, and delivers a claims-ready billing file. In the words of the MedTech Breakthrough judges, Nsight operates as "an extension of the clinical enterprise."

The clinical evidence behind the model

A fully managed model only matters if it produces results between visits, and the program's own data points that way. In its hypertension population, Nsight Health has observed an average systolic blood pressure reduction of approximately 11.5 mmHg overall, and approximately 29.6 mmHg among patients with Stage 2 hypertension, at or above the range reported in the published telemonitoring literature. It has also observed an approximately 55 mg/dL reduction in random glucose readings and meaningful blood pressure reductions in patients with chronic kidney disease. In a randomized evaluation of the legacy structured program model on which Nsight Health's heart failure monitoring was built, admissions fell by more than 50 percent reduction* and mortality fell by approximately 52 to 56 percent reduction*. These figures represent internal program data, are not the result of a peer-reviewed controlled trial, and individual results vary. The full evidence and sources are in our remote patient monitoring clinical outcomes analysis.

That model has been independently validated. Nsight Health was named the Best RPM Solution in the 2026 MedTech Breakthrough Awards, an independent program that evaluates platforms on clinical effectiveness, operational scalability, and the ability to sustain outcomes beyond initial deployment. Nsight also won a Gold Stevie Award for Best Health Products and Services at the 2026 American Business Awards, and a Silver Stevie for Fastest-Growing Company. Independent recognition of both what Nsight built and how fast it is growing points to the same conclusion: a clinical model that works.

The economic evidence

Better clinical management between visits should lower downstream cost, and an independent analysis points in that direction. Nsight Health engaged Optum to run a retrospective, matched-cohort, difference-in-difference analysis comparing Nsight patients with matched Medicare fee-for-service controls age 65 and older across three chronic disease cohorts. Nsight patients showed lower first-year total medical spending growth than matched controls, with estimated savings of approximately $2,500 to $3,000 per member per year before program costs. All six economic comparisons favored Nsight, with the diabetes and chronic kidney disease results showing the strongest statistical signal, though the findings did not reach the conventional 0.05 threshold for statistical significance. The results are best read as an early, directionally favorable economic signal rather than definitive proof. The full methodology is in our Nsight-Optum cost savings analysis.

Two things distinguish Nsight within the category. First, program breadth. Most companies offer one or two programs. Nsight delivers four under one roof, Remote Patient Monitoring, Chronic Care Management, Behavioral Health Integration, and Principal Care Management, through a single integration, so a provider can layer programs for a patient without coordinating multiple vendors. Second, alignment. Nsight operates at no upfront cost, with fees tied to successful reimbursement, so the model aligns with practice collections rather than adding fixed overhead. You keep clinical ownership. You bill, collect, and grow.

Common mistakes when comparing remote patient monitoring companies

Even organizations that run a careful process tend to stumble on the same few things. Knowing them in advance saves months of wasted effort.

• Buying software and underestimating the staffing it still requires. This is the most frequent and most costly mistake. A polished dashboard looks like a solution, but if no one on your team has time to work the data every day, the program stalls. Decide who does the clinical work before you decide which tool to buy.
• Choosing on device catalog size instead of the clinical model. A long list of supported devices is easy to compare and mostly beside the point. What determines outcomes is whether someone reviews the readings and acts on them, not how many gadgets are on the shelf.
• Ignoring program breadth. Picking a company that supports only one program means adding another vendor the moment a patient needs a second one. Breadth under one roof prevents a future of stitched-together contracts, dashboards, and billing workflows.
• Overlooking billing and documentation rigor. This is where reimbursement quietly leaks and where audit risk lives. A company that captures time, consent, and care plans to CMS standards protects both your revenue and your compliance posture.
• Treating it as a pilot instead of an operation. Programs that are launched and then left to run themselves fade. The companies worth choosing are built to sustain a program at production scale, not just to switch it on.

Avoiding these comes down to the same principle that organizes this whole guide: identify the type of company first, confirm who owns the clinical work, and validate that the partner can sustain the program. If you want to pressure-test a specific vendor against a full checklist, our decision guide walks through all nine criteria, and you can always schedule a demo to see a fully managed program up close.

The bottom line

The phrase "remote patient monitoring companies" hides real differences. Before comparing features, identify which of the five types you are looking at, because that determines how much work lands on your team. For most practices, groups, and value-based entities that lack spare staff, the fully managed clinical partner is the model that delivers proactive care without new hires. Within that category, evaluate on clinical staffing, program breadth, device logistics, EHR integration, compliant billing, and independent validation. Nsight Health was built to meet all six, and has the third-party recognition and national scale to back it. When you are ready to compare specific vendors, use our decision guide, and when you want to see the fully managed model in action, the next step is a conversation.

Frequently asked questions

What are the main types of remote patient monitoring companies?

There are five common types: software-only platforms, device and connectivity vendors, fully managed clinical partners, enterprise and hospital-at-home providers, and condition-specific point solutions. They differ most in how much of the clinical and operational work they take on versus leave to your staff.

What is the difference between a software-only RPM company and a fully managed one?

A software-only company gives you a dashboard, but your staff still reviews data, contacts patients, and manages the program. A fully managed clinical partner supplies the clinical team that does that work, so the practice keeps clinical ownership without adding headcount.

Which type of remote patient monitoring company is best?

There is no single best type. The right fit depends on your organization. Independent practices and groups without spare staff capacity are usually best served by a fully managed clinical partner, while large health systems may need enterprise or hospital-at-home capabilities for high-acuity use cases.

What should I look for when comparing RPM companies?

Screen on clinical staffing, program breadth, device logistics, EHR integration, billing and compliance rigor, and independent validation. Then apply a full evaluation framework to your finalists before signing.

Is Nsight Health a software company or a service company?

Nsight Health is a fully managed clinical partner. It provides the devices, the software, and a U.S.-based clinical team that monitors patients 24/7, handles enrollment and documentation, and prepares claims-ready billing, rather than handing you a tool to run yourself.

What awards has Nsight Health won?

Nsight Health was named the Best RPM Solution in the 2026 MedTech Breakthrough Awards and won a Gold Stevie Award for Best Health Products and Services, plus a Silver Stevie for Fastest-Growing Company, at the 2026 American Business Awards.

How many programs does Nsight Health offer?

Four programs under one roof: Remote Patient Monitoring, Chronic Care Management, Behavioral Health Integration, and Principal Care Management, delivered through a single integration so providers can layer programs for a patient without coordinating multiple vendors.

Does working with an RPM company require adding staff?

Not with a fully managed clinical partner. That model exists specifically so a practice can run a proactive program using the partner's clinical team, without hiring or reassigning its own staff.

How do RPM companies handle billing and reimbursement?

Approaches vary by type. Software and device vendors typically provide billing reports but leave claim capture to you. A fully managed partner captures the time and documentation each program requires and delivers a claims-ready billing file, though the practice bills and collects. Reimbursement amounts vary by geographic locality.

Is there evidence that Nsight Health's model improves outcomes?

Nsight Health reports internal program data including an average systolic blood pressure reduction of approximately 11.5 mmHg overall and approximately 29.6 mmHg in Stage 2 hypertension patients, plus an approximately 55 mg/dL reduction in random glucose readings. These are internal observations, not the result of a peer-reviewed controlled trial, and individual results vary. Heart failure figures cited by the program reflect a legacy structured heart failure program on which Nsight's model was built, not Nsight proprietary data.

Does Nsight Health reduce medical costs?

An independent retrospective analysis by Optum estimated savings of approximately $2,500 to $3,000 per member per year before program costs for Nsight patients versus matched Medicare fee-for-service controls. The findings were directionally favorable across all cohorts but did not reach the conventional 0.05 threshold for statistical significance, so they are best read as an early economic signal rather than a guarantee of savings.

Disclaimer: This article is for informational purposes only and does not constitute legal, billing, clinical, or financial advice. Comparisons of company types are general and may not reflect every vendor within a category. Award recognitions are those of the issuing organizations and reflect their opinions and criteria; they are not statements of fact and are not endorsements of any particular vendor by any government agency. Nsight Health does not guarantee any specific clinical outcome, reimbursement amount, or financial result. Clinical outcome figures (including blood pressure and glucose reductions) represent internal Nsight Health program data, are not the result of a peer-reviewed controlled trial, and individual patient results vary. *The greater than 50 percent heart failure admission reduction and the approximately 52 to 56 percent mortality reduction reflect data reported by a legacy structured heart failure remote monitoring program upon which Nsight Health's program was built and are not derived from Nsight Health proprietary data. The Nsight-Optum economic figures reflect a retrospective, matched-cohort, difference-in-difference analysis of Medicare fee-for-service patients age 65 and older; results were directionally favorable but did not reach conventional statistical significance (a p-value below 0.05), exclude program costs, and are not a guarantee of savings. Reimbursement varies by geographic locality and by your Medicare Administrative Contractor (MAC). CPT is a registered trademark of the American Medical Association.

Works Cited

MedTech Breakthrough. "Nsight Health Recognized for Remote Patient Monitoring Innovation in 2026 MedTech Breakthrough Awards Program." GlobeNewswire, 7 May 2026, www.globenewswire.com.

The Stevie Awards. "The 2026 American Business Awards: Company and Organization Category Winners." Stevie Awards, 2026, aba.stevieawards.com.

Leider, Harry L. "Remote Patient Monitoring Clinical Outcomes: The Evidence." Nsight Health, 2026, blog.nsightcare.com.

Leider, Harry L. "Remote Patient Monitoring Cost Savings in High-Risk Medicare Patients: Early Evidence From the Nsight-Optum Economic Analysis." Nsight Health, 2026, blog.nsightcare.com.

Centers for Medicare & Medicaid Services. "Calendar Year 2026 Medicare Physician Fee Schedule Final Rule." CMS.gov, 2025, www.cms.gov/medicare/payment/fee-schedules/physician.